Silvana Quaglini

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Cognitive Impairment

Diabetic Nephropathy

Randomized Controlled Trial

Top Venues

Aging clinical and experimental research

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Itske Fraterman, Barbara M Wollersheim, Valentina Tibollo, Savannah Lucia Catherina Glaser, Stephanie Medlock, Ronald Cornet, Matteo Gabetta, Vitali Gisko, Ella Barkan, Nicola di Flora, David Glasspool, Alexandra Kogan, Giordano Lanzola, Roy Leizer, Henk Mallo, Manuel Ottaviano, Mor Peleg, Lonneke V van de Poll-Franse, Nicole Veggiotti, Konrad Śniatała, Szymon Wilk, Enea Parimbelli, Silvana Quaglini, Mimma Rizzo, Laura Deborah Locati, Annelies H Boekhout, Lucia Sacchi, Sofie Wilgenhof
An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial. JMIR research protocols 12 (2023)
Claudia Rodella, Sara Bernini, Silvia Panzarasa, Elena Sinforiani, Picascia Marta, Silvana Quaglini, Elena Cavallini, Tomaso Vecchi, Cristina Tassorelli, Sara Bottiroli
A double-blind randomized controlled trial combining cognitive training (CoRe) and neurostimulation (tDCS) in the early stages of cognitive impairment. Aging clinical and experimental research (2021)
Gabriella Moroni, Giulia Porata, Francesca Raffiotta, Silvana Quaglini, Giulia Frontini, Lucia Sacchi, Valentina Binda, Marta Calatroni, Francesco Reggiani, Giovanni Banfi, Claudio Ponticelli
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival. Kidney360 3 (1) (2021)
Sara Bernini, Silvia Panzarasa, Marica Barbieri, Elena Sinforiani, Silvana Quaglini, Cristina Tassorelli, Sara Bottiroli
A double-blind randomized controlled trial of the efficacy of cognitive training delivered using two different methods in mild cognitive impairment in Parkinson's disease: preliminary report of benefits associated with the use of a computerized tool. Aging clinical and experimental research 33 (6) (2020)